Lonza, Marc Funk
In a major reshuffle at the top of Lonza, the company announced that Richard Ridinger, current CEO, would step down and be replaced by current COO, Marc Funk. The transition will occur on March 1, with Ridinger staying with the company until the end of April to facilitate the leadership transfer and then he will move into an advisory position until the end of 2019.
Funk joined Lonza in 2008, when he took on the position of chief legal and compliance officer. In 2014, he was promoted to COO and also served as board secretary from 2014 until 2014.
Prior to Lonza, Funk worked at Merck Serono for four years as head of corporate law and was the co-CEO of biotech, GeneProt – also for four years.
Funk said, “I am honoured to have been chosen as the new CEO of Lonza. Over the last few years, I have thoroughly enjoyed the challenge of advancing our Pharma & Biotech business and playing a key role in shaping its development into the world leadership position it enjoys today.”
